Tag Archives: U.S.

Pfizer’s keys to juggling 8 U.S. launches? Organization, accountability, clear goals

Think you’re busy? Take a look at Pfizer’s commercial team for oncology, which is currently launching four new drugs, three new indications for older drugs, and a biosimilar. And that’s just in the U.S. It’s taken some serious internal organizing on Pfizer’s part, but so far managing the multiple rollouts has been “done very well,”… Read More »

U.S. News updates best hospitals methodology for specialty rankings

Dive Brief: U.S. News & World Report is updating its methodology for ranking the country’s best hospitals, with the changes set to take effect when the new list is released July 30. One measure being added for the assessment of specialty hospitals is discharge of patients to the home, in line with previously announced additions… Read More »

J&J, U.S. states settle hip implant claims for $120 million

(Reuters) – Johnson & Johnson and its DePuy Orthopaedics unit have agreed to pay $ 120 million to resolve deceptive marketing claims by several U.S. states over the company’s metal-on-metal hip implants. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake/File Photo Attorneys general of 46… Read More »